Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent

Gene Therapy volume 14, pages 1175–1180 (2007)Cite this article

A Corrigendum to this article was published on 14 May 2009

Abstract

The development of new treatments in the post-genomic era requires methods for safe delivery of foreign genetic information in vivo. As a transient, natural and controllable alternative to recombinant viruses or plasmid DNA (pDNA), purified or in vitro transcribed messenger RNA (mRNA) can be used for the expression of any therapeutic protein in vitro and in vivo. As it has been shown previously, the simple injection of naked mRNA results in local uptake and expression. We show here that this process, in the skin, can greatly be modulated according to the injection solution composition and blocked by an excess of competing nucleic acids or a drug affecting cytosolic mobility. Different cell types at the site of injection can take up the foreign nucleic acid molecules and the protein translated from this is detected for no more than a few days. To test this gene transfer method in humans, we produced in vitro transcribed mRNA under good manufacturing practice (GMP) conditions in a dedicated facility. After injection into the human dermis, we could document the translation of the exogenous mRNA. Our results pave the way toward the use of mRNA as a vehicle for transient gene delivery in humans.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A et al. Direct gene transfer into mouse muscle in vivo. Science 1990; 247: 1465–1468.

    Article  CAS  Google Scholar 

  2. Robinson HL, Hunt LA, Webster RG . Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993; 11: 957–960.

    Article  CAS  PubMed  Google Scholar 

  3. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL, Dwarki VJ et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993; 259: 1745–1749.

    Article  CAS  PubMed  Google Scholar 

  4. Boczkowski D, Nair SK, Snyder D, Gilboa E . Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996; 184: 465–472.

    Article  CAS  Google Scholar 

  5. Carralot JP, Probst J, Hoerr I, Scheel B, Teufel R, Jung G et al. Polarization of the immunity induced by direct injection of naked globin UTR-stabilized mRNA vaccines. Cell Mol Life Sci 2004; 61: 2418–2424.

    Article  CAS  PubMed  Google Scholar 

  6. Conry RM, LoBuglio AF, Wright M, Sumerel L, Pike MJ, Johanning F et al. Characterization of a messenger RNA polynucleotide vaccine vector. Cancer Res 1995; 55: 1397–1400.

    CAS  PubMed  Google Scholar 

  7. Granstein RD, Ding W, Ozawa H . Induction of anti-tumor immunity with epidermal cells pulsed with tumor-derived RNA or intradermal administration of RNA. J Invest Dermatol 2000; 114: 632–636.

    Article  CAS  Google Scholar 

  8. Hoerr I, Obst R, Rammensee HG, Jung G . In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. Eur J Immunol 2000; 30: 1–7.

    Article  CAS  PubMed  Google Scholar 

  9. Pascolo S . Messenger RNA-based vaccines. Expert Opin Biol Ther 2004; 4: 1285–1294.

    Article  CAS  Google Scholar 

  10. Donnelly J, Berry K, Ulmer JB . Technical and regulatory hurdles for DNA vaccines. Int J Parasitol 2003; 33: 457–467.

    Article  CAS  PubMed  Google Scholar 

  11. Klinman DM, Takeno M, Ichino M, Gu M, Yamshchikov G, Mor G et al. DNA vaccines: safety and efficacy issues. Springer Semin Immunopathol 1997; 19: 245–256.

    Article  CAS  Google Scholar 

  12. Forg P, von Hoegen P, Dalemans W, Schirrmacher V . Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Therapy 1998; 5: 789–797.

    Article  CAS  Google Scholar 

  13. Lyons JC, Ross BD, Song CW . Enhancement of hyperthermia effect in vivo by amiloride and DIDS. Int J Radiat Oncol Biol Phys 1993; 25: 95–103.

    Article  CAS  PubMed  Google Scholar 

  14. Messiha FS . Neurotoxicity of chlorpromazine and modulation by amantadine as a function of mouse strain. Neurotoxicology 1991; 12: 571–581.

    CAS  PubMed  Google Scholar 

  15. Uma DP, Satish Rao BS, Kamath R . A method to score micronuclei in vivo using cytochalasin B-induced cytokinesis block. Mut Res 1998; 401: 33–37.

    Article  Google Scholar 

  16. Mehta RT, Hopfer RL, McQueen T, Juliano RL, Lopez-Berestein G . Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections. Antimicrob Agents Chemother 1987; 31: 1901–1903.

    Article  CAS  PubMed  Google Scholar 

  17. Benner SA . Extracellular ‘communicator RNA’. FEBS Lett 1988; 233: 225–228.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Fritz-Bender Stiftung. JP was supported by the DFG Graduiertenkolleg ‘infektionsbiologie’ 685 of Tübingen.

Author information

Authors and Affiliations

  1. Department of Immunology, Institute for Cell Biology, University of Tübingen, Tübingen, Germany

    J Probst, B Scheel, H-G Rammensee & S Pascolo

  2. CureVac GmbH, Tübingen, Germany

    J Probst, B Scheel, I Hoerr & S Pascolo

  3. Department of Dermatology, University of Tübingen, Tübingen, Germany

    B Weide

  4. Department of Radiology, Laboratory for Preclinical Imaging and Imaging Technology, University of Tübingen, Tübingen, Germany

    B J Pichler

Authors
  1. J Probst
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B Weide
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B Scheel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B J Pichler
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I Hoerr
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H-G Rammensee
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S Pascolo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Pascolo.

Additional information

Supplementary Information accompanies the paper on Gene Therapy website (http://www.nature.com/gt)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Probst, J., Weide, B., Scheel, B. et al. Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent. Gene Ther 14, 1175–1180 (2007). https://doi.org/10.1038/sj.gt.3302964

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302964

Keywords

This article is cited by

Search

Advanced search

Quick links